Increasing Viral Testing in the Emergency Department (InVITED)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01419899|
Recruitment Status : Completed
First Posted : August 18, 2011
Last Update Posted : August 7, 2013
|Condition or disease||Intervention/treatment||Phase|
|Drug Use HIV Hepatitis C||Behavioral: Brief motivational intervention||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||398 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||Phase 2/3 Clinical Trial of the Effect of a Brief Intervention on Uptake of Rapid Testing for HIV and Hepatitis C Among Emergency Department Patients|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||January 2012|
|Actual Study Completion Date :||January 2012|
Experimental: Brief Intervention
This arm of the study will receive an assessments survey followed by a brief intervention concerning the relationship between the participants use of drugs and/or sexual risk and rik for HIV and hepatitis C infections. Following the intervention the participants will be offered free rapid testing for HIV and hepatitis C.
Behavioral: Brief motivational intervention
A 20-30 minute motivational based discussion
No Intervention: Standard Care
This arm of the study will receive an assessments survey. Following the assessment the participants will be offered free rapid testing for HIV and hepatitis C.
- The agreement of the participant to be tested for HIV and hepatitis C [ Time Frame: Within four hours of being consented into the study ]We will measure the acceptance of free rapid testing for HIV and hepatitis C among the intervention and control groups
- Identifying risky sexual behaviors of study participants [ Time Frame: Within four hours of being consented into the study ]Identify factors that influence the relationship of BI and risk assessment vs. risk assessment alone on uptake of combined HIV and hepatitis C screening in the ED.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01419899
|United States, Rhode Island|
|Rhode Island Hospital Emergency Department|
|Providence, Rhode Island, United States, 02903|
|Principal Investigator:||Roland C Merchant, MD, ScD||Brown University|
|Principal Investigator:||Ted D Nirenberg, PhD||Brown University|